| |
|
|
|
|
|
|
|||
|
Blood, 1 January 2006, Vol. 107, No. 1, pp. 187-189. Prepublished online as a Blood First Edition Paper on August 25, 2005; DOI 10.1182/blood-2005-07-3059.
Submitted July 29, 2005
Transfusion Medicine Program, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA * Corresponding author; email: jzimrin{at}emory.edu.
Increased rates of bone marrow transplant (BMT) graft rejection are observed in patients whose illnesses necessitate chronic transfusion prior to BMT, such as sickle cell disease, thalassemia, or aplastic anemia. Because BMTs in this setting are routinely HLA matched, any immunization responsible for increased rejection is likely against minor histocompatibility antigens (mHAs). It has been assumed that contaminating leukocytes in red blood cell (RBC) units are the main source of immunization to mHAs. However, in this report we demonstrate that antigens on donor RBC are presented in the MHC class I pathway of recipient antigen presenting cells, resulting in activation and expansion of recipient CD8+ T cells specific for donor mHAs. Since human hematopoietic progenitor cells express many of the known mHAs, this observation provides a mechanism by which chronic transfusion of even stringently leukoreduced RBC may result in sufficient mHA immunization to increase the frequency of BMT rejection.
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||